Shares of ZIOPHARM Oncology (NASDAQ:ZIOP) were 16.8% higher as of 3:11 p.m. EDT on Tuesday. The big move in the biotech's share price is likely related to ZIOPHARM's announcement earlier in the day of changes to its board of directors.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,